#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18888	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	886.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1706	1706	T	1047	T,C	745,248	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18888	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	886.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	1047	C	1008	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	18888	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	886.2	0	HET	.	.	.	C451T	.	451	451	C	707	707	C	1080	C,T	800,233	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	36036	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3453	1035.0	0	.	n	.	0	T695C	SNP	695	695	T	1059	1059	C	1071	C,T	1030,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	36036	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3453	1035.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2002	2002	G	1097	G,A	481,581	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	36036	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3453	1035.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2335	2335	C	1149	C	1099	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	36036	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3453	1035.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2409	2409	A	1096	A	1059	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	36036	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3453	1035.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2961	2961	C	1083	C	1049	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2160	folP	855	855	100.0	folP.l15.c4.ctg.1	1522	140.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1011	1013	AGC	241;244;247	A;G;C	230;228;227	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	168.1	1	SNP	p	S91F	1	.	.	271	273	TTC	622	624	TTC	165;165;165	T;T;C	161;162;156	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	168.1	1	SNP	p	G95N	0	.	.	283	285	GGC	634	636	GGC	171;171;168	G;G;C	164;161;159	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3397	168.1	1	SNP	p	D95G	1	.	.	283	285	GGC	634	636	GGC	171;171;168	G;G;C	164;161;159	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1936	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1350	142.6	1	SNP	p	G45D	0	.	.	133	135	GGC	526	528	GGC	235;234;235	G;G;C	226;223;226	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	958	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1077	88.7	0	.	n	.	0	A197.	DEL	197	197	A	618	618	A	228	A	220	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6750	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2814	237.7	1	SNP	p	D86N	0	.	.	256	258	GAC	497	499	GAC	267;264;261	G;A;C	264;254;259	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6750	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2814	237.7	1	SNP	p	R87W	0	.	.	259	261	CGT	500	502	CGT	262;261;267	C;G;T	260;255;259	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6750	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2814	237.7	1	SNP	p	R87I	0	.	.	259	261	CGT	500	502	CGT	262;261;267	C;G;T	260;255;259	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6750	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2814	237.7	1	SNP	p	S87R	1	.	.	259	261	CGT	500	502	CGT	262;261;267	C;G;T	260;255;259	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6750	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2814	237.7	1	SNP	p	S88P	0	.	.	262	264	TCC	503	505	TCC	268;263;266	T;C;C	262;257;263	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4616	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2594	176.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1570	1572	GGC	241;242;240	G;G;C	234;233;228	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1171	1173	GCC	285;285;285	G;C;C	273;274;271	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1174	1176	ATG	286;286;289	A;T,A;G	273;273,1;273	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1186	1188	ACC	286;286;286	A;C;C	267;273;273	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1186	1188	ACC	286;286;286	A;C;C	267;273;273	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1687	1689	ACC	276;272;267	A;C;C	252;259;258	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1741	1743	GCG	240;239;239	G;C,G;G	237;235,1;235	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1741	1743	GCG	240;239;239	G;C,G;G	237;235,1;235	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1864	1866	GGT	217;216;217	G;G;T,C	206;202;204,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1873	1875	AGC	199;195;193	A,G;G;C	184,1;182;181	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4790	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2254	210.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1891	1893	CCG	143;148;149	C,G;C,G;G,C	119,7;125,2;123,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7220	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3084	232.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1660	1662	CCG	239;240;241	C;C;G	225;232;229	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2958	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1707	171.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	504	504	C	201	C	187	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	705	707	AAG	330;331;329	A;A;G	320;321;318	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	D121G	NONSYN	361	363	GAC	708	710	GGC	324;322;321	G;G;C	318;313;312	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	E212D	NONSYN	634	636	GAA	981	983	GAT	312;312;311	G;A;T,G	296;299;296,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	H213G	NONSYN	637	639	CAT	984	986	GGT	310;307;303	G;G,A;T,G	296;299,1;281,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	V215A	NONSYN	643	645	GTT	990	992	GCT	304;303;304	G;C;T	296;294;297	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	I218M	NONSYN	652	654	ATC	999	1001	ATG	294;294;294	A;T;G	286;289;283	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1116	1118	ACG	285;286;280	A,T;C,G;G	276,1;279,1;276	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1122	1124	GTT	281;283;280	G,T;T,C;T	271,1;274,1;274	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3698	porB1b	1047	1047	98.57	porB1b.l6.c4.ctg.1	1615	227.9	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1236	1238	AAC	275;272;272	A,G;A;C	264,1;263;263	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13496	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4855	276.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1562	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	930	165.6	1	SNP	p	V57M	1	.	.	169	171	ATG	399	401	ATG	309;307;303	A;T;G,T	302;297;293,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
